Latest Oncogenes Stories
Diverse pipeline compounds target key cancer pathways INDIANAPOLIS, April 20, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present early stage data from several targeted
DUBLIN, April 14, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/c2rl8f/oncogene) has announced the addition of the "Oncogene Inhibitors
A newly-discovered process used by the dividing cells in worms to make sure that the processes of gene expression is properly coupled to cell division to ensure that the organism can develop as expected – a finding that could also have implications for cancer research in humans.
CALGARY, March 5, 2015 /PRNewswire/ - Oncolytics Biotech(®) Inc.
-- Novel irreversible pan-erbB inhibitor is active against patient-derived GBM xenografts overexpressing EGFR, including the disease-driving EGFRvIII mutation MENLO PARK, Calif., Dec.
Studies Using Caris Molecular Intelligence(TM) Identify Standard as well as Novel Therapeutic Options Based on Molecular Characterization of Individual Patients' Tumors IRVING, Texas,
Study May Lead to More Targeted Treatments for Cancers and "Rasopathies" CINCINNATI, Nov.
SAN DIEGO, Nov. 6, 2014 /PRNewswire/ -- Trovagene, Inc.
Prospective blinded study demonstrates ability to accurately determine mutational status and monitor response to BRAF inhibitor therapy from urinary cell-free DNA SAN DIEGO, Oct.
BRAF V600E assay improves determination of mutational status and allows monitoring of treatment response SAN DIEGO, Oct.
- an ornament or knob in the shape of a flower
- In architecture, a floral ornament; specifically, the large conventional flower usually placed in the center of the abacus of a Corinthian capital or classic ceiling-caisson; also, the floreated termination of a Gothic finial.